

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.58952196 |
| 2 | T cell migration (GO:0072678) | 5.40856801 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.37794312 |
| 4 | leukocyte aggregation (GO:0070486) | 4.83718814 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.78384615 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.56499771 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.56499771 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.53498653 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.53264679 |
| 10 | mast cell activation (GO:0045576) | 4.53141171 |
| 11 | detection of other organism (GO:0098543) | 4.36979174 |
| 12 | detection of bacterium (GO:0016045) | 4.33304968 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.14199351 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.12651390 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.12651390 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12037961 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.06674938 |
| 18 | negative T cell selection (GO:0043383) | 4.03549041 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.03026390 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.02567148 |
| 21 | negative thymic T cell selection (GO:0045060) | 4.02055230 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.00658302 |
| 23 | cellular extravasation (GO:0045123) | 3.95901927 |
| 24 | interferon-gamma production (GO:0032609) | 3.91894991 |
| 25 | granulocyte activation (GO:0036230) | 3.90729050 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.89035536 |
| 27 | respiratory burst (GO:0045730) | 3.88632255 |
| 28 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.88542050 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.86903333 |
| 30 | positive regulation of mast cell activation (GO:0033005) | 3.83855271 |
| 31 | regulation of mast cell degranulation (GO:0043304) | 3.83025623 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.82788706 |
| 33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.77841043 |
| 34 | sequestering of actin monomers (GO:0042989) | 3.74826608 |
| 35 | mast cell activation involved in immune response (GO:0002279) | 3.74505514 |
| 36 | mast cell degranulation (GO:0043303) | 3.74505514 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.67809806 |
| 38 | lymphocyte chemotaxis (GO:0048247) | 3.61512034 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.57440154 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.55442012 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.53250608 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.52605613 |
| 43 | type I interferon signaling pathway (GO:0060337) | 3.52605613 |
| 44 | response to type I interferon (GO:0034340) | 3.52038878 |
| 45 | response to interleukin-15 (GO:0070672) | 3.51781331 |
| 46 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.50870117 |
| 47 | activated T cell proliferation (GO:0050798) | 3.45646287 |
| 48 | B cell mediated immunity (GO:0019724) | 3.44432817 |
| 49 | regulation of tolerance induction (GO:0002643) | 3.43949612 |
| 50 | detection of external biotic stimulus (GO:0098581) | 3.43202589 |
| 51 | regulation of mast cell activation (GO:0033003) | 3.42658527 |
| 52 | lymphocyte migration (GO:0072676) | 3.41564113 |
| 53 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.40239123 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39987952 |
| 55 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.39887957 |
| 56 | response to peptidoglycan (GO:0032494) | 3.37140070 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.36855871 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.34955186 |
| 59 | myeloid dendritic cell activation (GO:0001773) | 3.34896183 |
| 60 | regulation of regulatory T cell differentiation (GO:0045589) | 3.31983967 |
| 61 | B cell receptor signaling pathway (GO:0050853) | 3.31657449 |
| 62 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.29848939 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.29847283 |
| 64 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.28704694 |
| 65 | positive regulation of macrophage differentiation (GO:0045651) | 3.28091381 |
| 66 | response to protozoan (GO:0001562) | 3.27955913 |
| 67 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.26399889 |
| 68 | positive T cell selection (GO:0043368) | 3.25011144 |
| 69 | negative regulation of phagocytosis (GO:0050765) | 3.24789879 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.24076754 |
| 71 | defense response to protozoan (GO:0042832) | 3.23675511 |
| 72 | pinocytosis (GO:0006907) | 3.20242669 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 3.19753609 |
| 74 | thymic T cell selection (GO:0045061) | 3.18151630 |
| 75 | response to muramyl dipeptide (GO:0032495) | 3.17852147 |
| 76 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17526553 |
| 77 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.17294866 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 3.17294866 |
| 79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.15679121 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15447629 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.15316940 |
| 82 | negative regulation of innate immune response (GO:0045824) | 3.15177931 |
| 83 | positive regulation of B cell differentiation (GO:0045579) | 3.14416713 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 3.13063005 |
| 85 | modulation by symbiont of host defense response (GO:0052031) | 3.12048457 |
| 86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.12048457 |
| 87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.12048457 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.12048457 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 3.12048457 |
| 90 | positive regulation by symbiont of host defense response (GO:0052509) | 3.12048457 |
| 91 | natural killer cell activation (GO:0030101) | 3.11054078 |
| 92 | microglial cell activation (GO:0001774) | 3.09773110 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09686199 |
| 94 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.09478419 |
| 95 | leukocyte cell-cell adhesion (GO:0007159) | 3.09374226 |
| 96 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.08051040 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06067224 |
| 98 | positive regulation of isotype switching (GO:0045830) | 3.02620642 |
| 99 | leukocyte degranulation (GO:0043299) | 3.01588358 |
| 100 | detection of biotic stimulus (GO:0009595) | 3.01242765 |
| 101 | regulation of interferon-alpha production (GO:0032647) | 3.00297330 |
| 102 | T cell receptor signaling pathway (GO:0050852) | 2.98901858 |
| 103 | response to interferon-beta (GO:0035456) | 2.97197309 |
| 104 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.97086227 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 2.95752357 |
| 106 | dendritic cell chemotaxis (GO:0002407) | 2.95747475 |
| 107 | actin nucleation (GO:0045010) | 2.94998361 |
| 108 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.93602207 |
| 109 | response to host immune response (GO:0052572) | 2.93602207 |
| 110 | T cell selection (GO:0045058) | 2.92418057 |
| 111 | T cell costimulation (GO:0031295) | 2.92407709 |
| 112 | positive regulation of lamellipodium assembly (GO:0010592) | 2.92204804 |
| 113 | natural killer cell differentiation (GO:0001779) | 2.91559003 |
| 114 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.90775111 |
| 115 | positive regulation of interleukin-2 production (GO:0032743) | 2.90176264 |
| 116 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.90164782 |
| 117 | cellular response to interferon-beta (GO:0035458) | 2.89771019 |
| 118 | lymphocyte costimulation (GO:0031294) | 2.89092497 |
| 119 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86750952 |
| 120 | regulation of T cell tolerance induction (GO:0002664) | 2.85528248 |
| 121 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.84762544 |
| 122 | positive regulation of B cell mediated immunity (GO:0002714) | 2.84762544 |
| 123 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84285932 |
| 124 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.83855632 |
| 125 | macrophage activation (GO:0042116) | 2.83841943 |
| 126 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83731212 |
| 127 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83731212 |
| 128 | regulation of response to interferon-gamma (GO:0060330) | 2.83548295 |
| 129 | regulation of antigen processing and presentation (GO:0002577) | 2.82509522 |
| 130 | positive regulation of granulocyte differentiation (GO:0030854) | 2.81155545 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79832756 |
| 132 | regulation of cell killing (GO:0031341) | 2.79121898 |
| 133 | myeloid dendritic cell differentiation (GO:0043011) | 2.78850541 |
| 134 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.78794485 |
| 135 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.78687151 |
| 136 | cellular defense response (GO:0006968) | 2.78536043 |
| 137 | positive regulation of interferon-gamma production (GO:0032729) | 2.77955022 |
| 138 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.75833974 |
| 139 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72589019 |
| 140 | neutrophil activation (GO:0042119) | 2.70677000 |
| 141 | tolerance induction (GO:0002507) | 2.70140802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.08123778 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.55634623 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.51269313 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00181277 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.93160072 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.91257898 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.79989011 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.46133526 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.18237458 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02170372 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.92460668 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88045950 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86255067 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74925246 |
| 15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67500813 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.67317954 |
| 17 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.65046145 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50302318 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.49871048 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.49801556 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.34249794 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31017716 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22902742 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.22229531 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21177950 |
| 26 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17913630 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.14222859 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.10111667 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08211228 |
| 30 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.07596519 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07051407 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97043442 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.96621012 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90814857 |
| 35 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88179338 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.87656232 |
| 37 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83749250 |
| 38 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.83637439 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78181510 |
| 40 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74815251 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73066450 |
| 42 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64026314 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57206973 |
| 44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54478959 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54048524 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51759927 |
| 47 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51399054 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49732080 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48138614 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47378115 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46485892 |
| 52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44148340 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43841138 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41629703 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.40312041 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40061757 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39350429 |
| 58 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37312178 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37281148 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35547611 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33844335 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32845361 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32632783 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31902747 |
| 65 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31181314 |
| 66 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.31162087 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26960721 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25361936 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23347282 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23295232 |
| 71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22870447 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22230616 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.20512056 |
| 74 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18411161 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18173972 |
| 76 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.18015842 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16793174 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15603210 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15532890 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14237632 |
| 81 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13756087 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10871061 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10775544 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10717745 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09993800 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08787794 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08256807 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06774080 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05110971 |
| 90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.03574616 |
| 91 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.02301344 |
| 92 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00497813 |
| 93 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99884921 |
| 94 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99013433 |
| 95 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.97780265 |
| 96 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97742170 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96912053 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96485335 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96375905 |
| 100 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96276373 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95483242 |
| 102 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95442959 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94653721 |
| 104 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92495921 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92101052 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90795335 |
| 107 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.88705223 |
| 108 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88291882 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87631548 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87631504 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86526441 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86286670 |
| 113 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.85637846 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.85242762 |
| 115 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.83634386 |
| 116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82757661 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82726695 |
| 118 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.82143151 |
| 119 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81601584 |
| 120 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81382650 |
| 121 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80742949 |
| 122 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.78785612 |
| 123 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77163384 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.75498440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40151609 |
| 2 | MP0005671_abnormal_response_to | 4.04740062 |
| 3 | MP0009785_altered_susceptibility_to | 3.88710482 |
| 4 | MP0003436_decreased_susceptibility_to | 3.46831026 |
| 5 | MP0006082_CNS_inflammation | 3.44691792 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.20122484 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.13874445 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.11673536 |
| 9 | MP0005025_abnormal_response_to | 3.06864499 |
| 10 | MP0000685_abnormal_immune_system | 3.05123163 |
| 11 | MP0003724_increased_susceptibility_to | 2.87412667 |
| 12 | MP0001800_abnormal_humoral_immune | 2.87247776 |
| 13 | MP0002419_abnormal_innate_immunity | 2.85129073 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.74478468 |
| 15 | MP0002723_abnormal_immune_serum | 2.74083103 |
| 16 | MP0001790_abnormal_immune_system | 2.69674138 |
| 17 | MP0005387_immune_system_phenotype | 2.69674138 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.65293771 |
| 19 | * MP0001819_abnormal_immune_cell | 2.63826115 |
| 20 | MP0002405_respiratory_system_inflammati | 2.44816772 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.39077519 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.39018369 |
| 23 | MP0002398_abnormal_bone_marrow | 2.32935615 |
| 24 | MP0000716_abnormal_immune_system | 2.12755594 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.10632636 |
| 26 | MP0003303_peritoneal_inflammation | 2.09694727 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.08755251 |
| 28 | MP0002396_abnormal_hematopoietic_system | 2.07338134 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.02596876 |
| 30 | MP0002006_tumorigenesis | 1.99391132 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.92112669 |
| 32 | * MP0002722_abnormal_immune_system | 1.88893507 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.85873982 |
| 34 | MP0002429_abnormal_blood_cell | 1.79305199 |
| 35 | MP0001853_heart_inflammation | 1.67515462 |
| 36 | MP0004947_skin_inflammation | 1.67040532 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.66855004 |
| 38 | MP0004510_myositis | 1.66752005 |
| 39 | MP0003448_altered_tumor_morphology | 1.65845911 |
| 40 | MP0008469_abnormal_protein_level | 1.58593679 |
| 41 | MP0002132_abnormal_respiratory_system | 1.56807257 |
| 42 | MP0000858_altered_metastatic_potential | 1.53966588 |
| 43 | * MP0000703_abnormal_thymus_morphology | 1.53952950 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.53804220 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.52756836 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.52756836 |
| 47 | MP0000490_abnormal_crypts_of | 1.50487368 |
| 48 | MP0001873_stomach_inflammation | 1.47600937 |
| 49 | MP0000343_altered_response_to | 1.45251930 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.44755111 |
| 51 | MP0003866_abnormal_defecation | 1.37833510 |
| 52 | MP0002933_joint_inflammation | 1.34495297 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.31991434 |
| 54 | MP0005310_abnormal_salivary_gland | 1.26163278 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.18883081 |
| 56 | MP0009278_abnormal_bone_marrow | 1.18081895 |
| 57 | MP0009764_decreased_sensitivity_to | 1.16744873 |
| 58 | MP0008004_abnormal_stomach_pH | 1.14104023 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.13895876 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.11700600 |
| 61 | MP0005166_decreased_susceptibility_to | 1.09283136 |
| 62 | MP0008260_abnormal_autophagy | 1.08414530 |
| 63 | MP0003828_pulmonary_edema | 1.08369079 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.06667452 |
| 65 | * MP0002019_abnormal_tumor_incidence | 1.01877610 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.99716824 |
| 67 | MP0001851_eye_inflammation | 0.99508507 |
| 68 | MP0004883_abnormal_blood_vessel | 0.99277492 |
| 69 | MP0009763_increased_sensitivity_to | 0.98985239 |
| 70 | MP0010307_abnormal_tumor_latency | 0.98755789 |
| 71 | MP0008007_abnormal_cellular_replicative | 0.94209536 |
| 72 | MP0003045_fibrosis | 0.93828882 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.92653794 |
| 74 | MP0009840_abnormal_foam_cell | 0.89989769 |
| 75 | MP0000015_abnormal_ear_pigmentation | 0.87407217 |
| 76 | MP0003075_altered_response_to | 0.87168512 |
| 77 | MP0003693_abnormal_embryo_hatching | 0.86661564 |
| 78 | MP0003077_abnormal_cell_cycle | 0.86396459 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.82639167 |
| 80 | MP0004381_abnormal_hair_follicle | 0.81208282 |
| 81 | MP0008057_abnormal_DNA_replication | 0.78484512 |
| 82 | MP0004130_abnormal_muscle_cell | 0.77601200 |
| 83 | MP0010094_abnormal_chromosome_stability | 0.76458462 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.76056447 |
| 85 | MP0005390_skeleton_phenotype | 0.73506793 |
| 86 | MP0005164_abnormal_response_to | 0.70994257 |
| 87 | MP0005451_abnormal_body_composition | 0.69360222 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.69010639 |
| 89 | MP0003186_abnormal_redox_activity | 0.65582254 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.65574729 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.64783866 |
| 92 | MP0008058_abnormal_DNA_repair | 0.64449999 |
| 93 | MP0000604_amyloidosis | 0.63313680 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.61495967 |
| 95 | MP0003795_abnormal_bone_structure | 0.60411629 |
| 96 | MP0008874_decreased_physiological_sensi | 0.59304273 |
| 97 | MP0005083_abnormal_biliary_tract | 0.58940559 |
| 98 | MP0002009_preneoplasia | 0.58271040 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.57845537 |
| 100 | MP0000371_diluted_coat_color | 0.57317091 |
| 101 | MP0003111_abnormal_nucleus_morphology | 0.57040520 |
| 102 | MP0000313_abnormal_cell_death | 0.56360978 |
| 103 | MP0001663_abnormal_digestive_system | 0.56245863 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.55556287 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.55165171 |
| 106 | MP0005023_abnormal_wound_healing | 0.55118509 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.54844116 |
| 108 | MP0008873_increased_physiological_sensi | 0.54617729 |
| 109 | MP0000249_abnormal_blood_vessel | 0.54301125 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.53359733 |
| 111 | MP0004957_abnormal_blastocyst_morpholog | 0.53064355 |
| 112 | MP0000920_abnormal_myelination | 0.51928609 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.49832725 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.49184471 |
| 115 | MP0000609_abnormal_liver_physiology | 0.48912883 |
| 116 | MP0003690_abnormal_glial_cell | 0.48719972 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.48216228 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.46795696 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.45746329 |
| 120 | MP0005388_respiratory_system_phenotype | 0.43767130 |
| 121 | MP0002133_abnormal_respiratory_system | 0.43767130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.34759035 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.17211109 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.40657720 |
| 4 | Myositis (HP:0100614) | 4.70517554 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.62088067 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.38250775 |
| 7 | T lymphocytopenia (HP:0005403) | 4.37091691 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.33266877 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.30193865 |
| 10 | Abnormality of T cell number (HP:0011839) | 4.23532286 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.03087817 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.95927296 |
| 13 | Recurrent skin infections (HP:0001581) | 3.94729750 |
| 14 | Pustule (HP:0200039) | 3.92922331 |
| 15 | Stomatitis (HP:0010280) | 3.87519305 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.83783369 |
| 17 | Obstructive lung disease (HP:0006536) | 3.80102047 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80102047 |
| 19 | Orchitis (HP:0100796) | 3.78864199 |
| 20 | IgM deficiency (HP:0002850) | 3.77023940 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75390594 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75390594 |
| 23 | Optic neuritis (HP:0100653) | 3.72586455 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.72586455 |
| 25 | Recurrent viral infections (HP:0004429) | 3.70705566 |
| 26 | Abnormality of T cells (HP:0002843) | 3.63236052 |
| 27 | Petechiae (HP:0000967) | 3.48292500 |
| 28 | Severe combined immunodeficiency (HP:0004430) | 3.40379978 |
| 29 | Chronic otitis media (HP:0000389) | 3.38894078 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.33006406 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.31196722 |
| 32 | Gingivitis (HP:0000230) | 3.25382253 |
| 33 | Meningitis (HP:0001287) | 3.23595556 |
| 34 | Combined immunodeficiency (HP:0005387) | 3.20736065 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.17037043 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.17037043 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 3.17037043 |
| 38 | Recurrent bronchitis (HP:0002837) | 3.16292256 |
| 39 | Increased IgM level (HP:0003496) | 3.08042529 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 3.07056733 |
| 41 | Vasculitis (HP:0002633) | 3.04712450 |
| 42 | Nasal polyposis (HP:0100582) | 3.03005059 |
| 43 | IgG deficiency (HP:0004315) | 3.01137288 |
| 44 | Cellulitis (HP:0100658) | 2.93903777 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.87890538 |
| 46 | Leukocytosis (HP:0001974) | 2.87521855 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.85666240 |
| 48 | Chest pain (HP:0100749) | 2.83233009 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.82307310 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.81592786 |
| 51 | Thyroiditis (HP:0100646) | 2.80006201 |
| 52 | Thrombocytosis (HP:0001894) | 2.78562227 |
| 53 | Abnormal platelet volume (HP:0011876) | 2.77377626 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.75105502 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.74148781 |
| 56 | Prostate neoplasm (HP:0100787) | 2.70382559 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.68192214 |
| 58 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64829783 |
| 59 | Encephalitis (HP:0002383) | 2.63426621 |
| 60 | Lymphopenia (HP:0001888) | 2.63346719 |
| 61 | Epistaxis (HP:0000421) | 2.61409322 |
| 62 | Agnosia (HP:0010524) | 2.58214376 |
| 63 | Basal ganglia calcification (HP:0002135) | 2.57229797 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56539162 |
| 65 | Hemoptysis (HP:0002105) | 2.52650218 |
| 66 | Episodic fever (HP:0001954) | 2.51808125 |
| 67 | Urticaria (HP:0001025) | 2.50307562 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.48568335 |
| 69 | Increased serum ferritin (HP:0003281) | 2.47956202 |
| 70 | Pulmonary embolism (HP:0002204) | 2.46919924 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 2.46459070 |
| 72 | Arterial thrombosis (HP:0004420) | 2.46064043 |
| 73 | Abnormality of eosinophils (HP:0001879) | 2.45513630 |
| 74 | Gingival bleeding (HP:0000225) | 2.43051899 |
| 75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42383680 |
| 76 | Hypochromic anemia (HP:0001931) | 2.42078738 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.39983138 |
| 78 | Glomerulonephritis (HP:0000099) | 2.35823707 |
| 79 | Gastrointestinal infarctions (HP:0005244) | 2.34787107 |
| 80 | Joint swelling (HP:0001386) | 2.34718951 |
| 81 | Loss of speech (HP:0002371) | 2.32039961 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.30730291 |
| 83 | Menorrhagia (HP:0000132) | 2.29359493 |
| 84 | Dysostosis multiplex (HP:0000943) | 2.27684971 |
| 85 | Chronic diarrhea (HP:0002028) | 2.27335830 |
| 86 | Hypoplasia of the thymus (HP:0000778) | 2.26262601 |
| 87 | Anorexia (HP:0002039) | 2.25637631 |
| 88 | Colitis (HP:0002583) | 2.25249808 |
| 89 | Purpura (HP:0000979) | 2.24751179 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 2.23621457 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.23519594 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.22763578 |
| 93 | Agammaglobulinemia (HP:0004432) | 2.20614885 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20239669 |
| 95 | Periodontitis (HP:0000704) | 2.20090903 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 2.17492585 |
| 97 | Lymphoma (HP:0002665) | 2.13673345 |
| 98 | Amyloidosis (HP:0011034) | 2.12958500 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.12738372 |
| 100 | Eosinophilia (HP:0001880) | 2.10554255 |
| 101 | Increased mean platelet volume (HP:0011877) | 2.09374918 |
| 102 | Increased IgE level (HP:0003212) | 2.08382674 |
| 103 | Recurrent pneumonia (HP:0006532) | 2.04261028 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 2.01484366 |
| 105 | Reticulocytopenia (HP:0001896) | 2.01400544 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.00882536 |
| 107 | Albinism (HP:0001022) | 2.00657087 |
| 108 | Premature loss of primary teeth (HP:0006323) | 2.00372011 |
| 109 | Hematochezia (HP:0002573) | 1.99621575 |
| 110 | Microcytic anemia (HP:0001935) | 1.99366511 |
| 111 | Osteomyelitis (HP:0002754) | 1.99181560 |
| 112 | Glomerulopathy (HP:0100820) | 1.98056847 |
| 113 | Thoracic kyphosis (HP:0002942) | 1.95923862 |
| 114 | Gangrene (HP:0100758) | 1.94477401 |
| 115 | Granulocytopenia (HP:0001913) | 1.94143482 |
| 116 | Skin ulcer (HP:0200042) | 1.93000551 |
| 117 | Cheilitis (HP:0100825) | 1.92851342 |
| 118 | IgA deficiency (HP:0002720) | 1.90967556 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.90939486 |
| 120 | Polyneuropathy (HP:0001271) | 1.90114420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.54329498 |
| 2 | MAP4K1 | 4.44185593 |
| 3 | BLK | 3.16288082 |
| 4 | ZAP70 | 3.15860739 |
| 5 | IRAK4 | 3.06121436 |
| 6 | NME2 | 2.83316476 |
| 7 | IKBKE | 2.75173549 |
| 8 | TBK1 | 2.56444621 |
| 9 | TYK2 | 2.50420545 |
| 10 | KIT | 2.49233070 |
| 11 | JAK3 | 2.46558223 |
| 12 | MAP3K14 | 2.38082589 |
| 13 | TEC | 2.22840200 |
| 14 | PRPF4B | 2.10427061 |
| 15 | TESK2 | 2.06379862 |
| 16 | PIM2 | 1.96960581 |
| 17 | MAP3K13 | 1.94107968 |
| 18 | KDR | 1.88841854 |
| 19 | ITK | 1.84377354 |
| 20 | * BTK | 1.83313268 |
| 21 | LCK | 1.81044901 |
| 22 | SYK | 1.79391868 |
| 23 | STK10 | 1.76614366 |
| 24 | BUB1 | 1.76455095 |
| 25 | RIPK4 | 1.64798053 |
| 26 | FGR | 1.63613555 |
| 27 | IKBKB | 1.62410632 |
| 28 | JAK1 | 1.61626315 |
| 29 | CSF1R | 1.58494659 |
| 30 | CSK | 1.57909576 |
| 31 | SIK3 | 1.44453439 |
| 32 | MAP3K12 | 1.40297300 |
| 33 | MAP3K3 | 1.34317066 |
| 34 | TAOK3 | 1.27557073 |
| 35 | TAOK1 | 1.26903710 |
| 36 | * HCK | 1.25390639 |
| 37 | * LYN | 1.23648988 |
| 38 | FGFR4 | 1.21630158 |
| 39 | IRAK3 | 1.19408331 |
| 40 | FES | 1.17645345 |
| 41 | LRRK2 | 1.10437660 |
| 42 | ERN1 | 1.09952795 |
| 43 | BMPR2 | 1.09862445 |
| 44 | PIM1 | 1.07705249 |
| 45 | GRK6 | 1.07173528 |
| 46 | RPS6KA4 | 1.04900426 |
| 47 | NLK | 1.00347798 |
| 48 | FLT3 | 0.99598845 |
| 49 | CAMKK2 | 0.98503430 |
| 50 | CLK1 | 0.97695010 |
| 51 | NEK9 | 0.96825011 |
| 52 | TGFBR2 | 0.96335559 |
| 53 | MST4 | 0.92586820 |
| 54 | PDK1 | 0.91796688 |
| 55 | MAP3K1 | 0.90142440 |
| 56 | MAP2K3 | 0.85433097 |
| 57 | ADRBK2 | 0.85226674 |
| 58 | FGFR3 | 0.84867721 |
| 59 | TAOK2 | 0.83898513 |
| 60 | JAK2 | 0.77833358 |
| 61 | STK4 | 0.75300967 |
| 62 | MAPK12 | 0.74819922 |
| 63 | TNK2 | 0.74471316 |
| 64 | TESK1 | 0.72041397 |
| 65 | YES1 | 0.70728794 |
| 66 | ACVR1B | 0.69107909 |
| 67 | PKN2 | 0.67233911 |
| 68 | PTK2B | 0.67110772 |
| 69 | EPHB1 | 0.66652863 |
| 70 | MAP3K11 | 0.66298599 |
| 71 | CHUK | 0.65838036 |
| 72 | MAP3K10 | 0.65807028 |
| 73 | PDPK1 | 0.65663261 |
| 74 | MAPK7 | 0.65307026 |
| 75 | PRKD2 | 0.64109196 |
| 76 | KSR2 | 0.63509293 |
| 77 | MARK2 | 0.62501974 |
| 78 | GRK7 | 0.62250015 |
| 79 | BMX | 0.62055696 |
| 80 | CAMKK1 | 0.58681775 |
| 81 | MARK3 | 0.57380015 |
| 82 | EEF2K | 0.55274323 |
| 83 | PIK3CG | 0.55231151 |
| 84 | MAP3K7 | 0.54818197 |
| 85 | MAP2K2 | 0.52240450 |
| 86 | CDK4 | 0.51632992 |
| 87 | PBK | 0.51098280 |
| 88 | CDC42BPA | 0.50678851 |
| 89 | TLK1 | 0.50424424 |
| 90 | PTK6 | 0.50331480 |
| 91 | PRKCQ | 0.50225035 |
| 92 | DAPK1 | 0.49577940 |
| 93 | TRIB3 | 0.48319460 |
| 94 | RPS6KA6 | 0.48103225 |
| 95 | PRKCD | 0.47440737 |
| 96 | TGFBR1 | 0.47282240 |
| 97 | EIF2AK2 | 0.46483094 |
| 98 | ABL1 | 0.45588687 |
| 99 | CDC7 | 0.43312378 |
| 100 | HIPK2 | 0.43233736 |
| 101 | STK24 | 0.42854878 |
| 102 | DAPK3 | 0.42826346 |
| 103 | CDK6 | 0.41793156 |
| 104 | WEE1 | 0.40890318 |
| 105 | ILK | 0.40257664 |
| 106 | SCYL2 | 0.40176698 |
| 107 | EIF2AK3 | 0.38868941 |
| 108 | DYRK1B | 0.38085092 |
| 109 | RPS6KC1 | 0.37565591 |
| 110 | RPS6KL1 | 0.37565591 |
| 111 | FYN | 0.37188284 |
| 112 | RET | 0.36886864 |
| 113 | MAP2K6 | 0.36762055 |
| 114 | IRAK1 | 0.36646734 |
| 115 | ABL2 | 0.36323055 |
| 116 | RPS6KA5 | 0.35057694 |
| 117 | MAP3K5 | 0.34902865 |
| 118 | MOS | 0.34479265 |
| 119 | PAK4 | 0.34401251 |
| 120 | MAPKAPK2 | 0.33654791 |
| 121 | NEK2 | 0.33392300 |
| 122 | MAPK11 | 0.32455670 |
| 123 | EGFR | 0.31665590 |
| 124 | ATR | 0.31411582 |
| 125 | CDK7 | 0.31171960 |
| 126 | IRAK2 | 0.31110990 |
| 127 | MAPK4 | 0.30929349 |
| 128 | SIK1 | 0.30732562 |
| 129 | MATK | 0.30177207 |
| 130 | MUSK | 0.29709509 |
| 131 | IGF1R | 0.27320787 |
| 132 | SIK2 | 0.26932997 |
| 133 | VRK1 | 0.26854646 |
| 134 | TTN | 0.26426522 |
| 135 | INSR | 0.26301720 |
| 136 | PRKD1 | 0.25838731 |
| 137 | DAPK2 | 0.23481000 |
| 138 | EPHA3 | 0.22843960 |
| 139 | ARAF | 0.22835533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46636602 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.37589692 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92619014 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.76916898 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63576861 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63363996 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.52916377 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.46320547 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45670121 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.37279568 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.33042611 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10042551 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07852657 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04428758 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 2.01412649 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.96634369 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.91144624 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88726743 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.86846501 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.69616439 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68916210 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67581576 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65190610 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.58615176 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52977712 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47252642 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45269844 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.43939859 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42602317 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.42307407 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42145582 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.42079238 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.41955077 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.37625112 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.36605083 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32893276 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31818980 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28540806 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27773097 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.27298230 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24671975 |
| 42 | Proteasome_Homo sapiens_hsa03050 | 1.24293804 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21413097 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.19642930 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.18227473 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17127028 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16804591 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15512579 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14770548 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13830203 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08978795 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.04745872 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 1.00687696 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98867730 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96625542 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.95627085 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91758034 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.89027728 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89014624 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85534810 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84633754 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80840580 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.73701880 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.73492353 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73251589 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72123722 |
| 67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71600992 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66817972 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65397088 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.63635229 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62481275 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62210827 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60685613 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59929868 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58469726 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58020184 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54336249 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54060875 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53594428 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52498855 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51860296 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51468333 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50271007 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50235410 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49311523 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47620502 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45710938 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45632146 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43539259 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42999228 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40765049 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39954157 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39309689 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37924892 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37862036 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.37319283 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.37113450 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36766834 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36542780 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35864840 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35651829 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35259389 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.35130797 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34187784 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34136834 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33602046 |
| 107 | RNA degradation_Homo sapiens_hsa03018 | 0.32717214 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32404933 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30864195 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30702352 |
| 111 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30249301 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29863795 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29160191 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28621047 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.27566274 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27382565 |
| 117 | RNA polymerase_Homo sapiens_hsa03020 | 0.27348575 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.26940331 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24949522 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24332747 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23793366 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22929309 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22533180 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21142279 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20523043 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20372420 |

